{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:54:28Z","timestamp":1781769268325,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019500","name":"Northern Private University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jgar.2026.04.012","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T08:57:22Z","timestamp":1776243442000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Analysis of antimicrobial consumption in Peruvian public health services during the COVID-19 pandemic: A GLASS-AMU-based study"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8670-3964","authenticated-orcid":false,"given":"Marcelo","family":"Cardenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8370-653X","authenticated-orcid":false,"given":"Cirene","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5459-3532","authenticated-orcid":false,"given":"Diego","family":"Monta\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6887-2599","authenticated-orcid":false,"given":"Guillermo","family":"Salvatierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2026.04.012_bib0001","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.jgar.2026.04.012_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.glmedi.2024.100081","article-title":"Antimicrobial resistance: impacts, challenges, and future prospects","volume":"2","author":"Ahmed","year":"2024","journal-title":"J Med Surg Public Health"},{"key":"10.1016\/j.jgar.2026.04.012_bib0003","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cmi.2015.12.002","article-title":"The negative impact of antibiotic resistance","volume":"22","author":"Friedman","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2026.04.012_bib0004","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2026.04.012_bib0005","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2026.04.012_bib0006","series-title":"Global Framework for Development & Stewardship to Combat Antimicrobial Resistance: Draft","year":"2018"},{"key":"10.1016\/j.jgar.2026.04.012_bib0007","series-title":"Plan Multisectorial para enfrentar la resistencia a los antimicrobianos","year":"2019"},{"key":"10.1016\/j.jgar.2026.04.012_bib0008","series-title":"Unidad Funcional del Programa de Optimizaci\u00f3n de Uso de Antimicrobianos (UF-PROA) INSN","year":"2022"},{"key":"10.1016\/j.jgar.2026.04.012_bib0009","series-title":"Resoluci\u00f3n Ministerial N.\u00b0 170-2022-MINSA","author":"MINSA (Ministerio de Salud)","year":"2022"},{"key":"10.1016\/j.jgar.2026.04.012_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297921","article-title":"Global antimicrobial resistance and use surveillance system (GLASS 2022): investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries","volume":"19","author":"Ajulo","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2026.04.012_bib0011","series-title":"Global Antimicrobial Resistance and Use Surveillance System (GLASS)","year":"2015"},{"key":"10.1016\/j.jgar.2026.04.012_bib0012","series-title":"Global antimicrobial resistance and use surveillance system (GLASS) report: 2022","year":"2022"},{"key":"10.1016\/j.jgar.2026.04.012_bib0013","series-title":"Antibiotic use: Total use of antibiotics expressed as DDD per 1000 inhabitants per day","year":"2025"},{"key":"10.1016\/j.jgar.2026.04.012_bib0014","unstructured":"World Health Organization (WHO). AWaRe classification of antibiotics for evaluation and monitoring of use, 2023 2023. https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.04 (accessed February 18, 2026)."},{"key":"10.1016\/j.jgar.2026.04.012_bib0015","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41591-021-01381-y","article-title":"Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries","volume":"27","author":"Haldane","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jgar.2026.04.012_bib0016","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/s41598-024-55540-5","article-title":"Impact of COVID-19 on antibiotic usage in primary care: a retrospective analysis","volume":"14","author":"Romaszko-Wojtowicz","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2026.04.012_bib0017","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3390\/antibiotics10060745","article-title":"Antimicrobial use in COVID-19 patients in the first phase of the SARS-CoV-2 pandemic: A scoping review","volume":"10","author":"Cong","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.jgar.2026.04.012_bib0018","article-title":"Uso de antibi\u00f3ticos en pacientes con COVID-19 en un hospital nacional de Lima","volume":"16","author":"Carrasco-Lozano","year":"2023","journal-title":"Per\u00fa, Rev Cuerpo M\u00e9d Hosp Nac Almanzor Aguinaga Asenjo"},{"key":"10.1016\/j.jgar.2026.04.012_bib0019","series-title":"Decreto Supremo N.\u00b0 044-2020-PCM","year":"2020"},{"key":"10.1016\/j.jgar.2026.04.012_bib0020","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/antibiotics12020318","article-title":"Impact of COVID-19 Pandemic in antibiotic consumption in Navarre (Spain): an interrupted time series analysis","volume":"12","author":"Alzueta","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.jgar.2026.04.012_bib0021","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/antibiotics12010126","article-title":"An improvement in the antimicrobial resistance patterns of urinary isolates in the out-of-hospital setting following decreased community use of antibiotics during the COVID-19 pandemic","volume":"12","author":"Tedeschi","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.jgar.2026.04.012_bib0022","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad096","article-title":"COVID-19 and outpatient antibiotic prescriptions in the United States: A county-level analysis","volume":"10","author":"Hamilton","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2026.04.012_bib0023","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmi.2021.10.013","article-title":"The impact of COVID-19 on community antibiotic use in Canada: an ecological study","volume":"28","author":"Knight","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2026.04.012_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.844818","article-title":"Barberato-Filho S. Consumption trends of antibiotics in Brazil during the COVID-19 pandemic","volume":"13","author":"Del Fiol","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jgar.2026.04.012_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39532-5","article-title":"Leveraging the COVID-19 pandemic as a natural experiment to assess changes in antibiotic use and antibiotic-resistant E. coli carriage in semi-rural Ecuador","volume":"13","author":"Amato","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2026.04.012_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101848","article-title":"Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020\u20132022","volume":"57","author":"Nandi","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jgar.2026.04.012_bib0027","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/jac\/dkac028","article-title":"Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19)","volume":"77","author":"Khouja","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.04.012_bib0028","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/antibiotics14030240","article-title":"National Antimicrobial Consumption in Latin America and the Caribbean: measurements and results from 2019\u20132022","volume":"14","author":"Marin","year":"2025","journal-title":"Antibiotics"},{"key":"10.1016\/j.jgar.2026.04.012_bib0029","first-page":"33","article-title":"Clinical effectiveness of macrolides in diseases of the airways: beyond the antimicrobial effects","volume":"26","author":"Kryfti","year":"2013","journal-title":"Pneumon"},{"key":"10.1016\/j.jgar.2026.04.012_bib0030","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00394-19","article-title":"Azithromycin protects against Zika Virus infection by upregulating virus-induced type I and III interferon responses","volume":"63","author":"Li","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.012_bib0031","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1021\/acsinfecdis.5b00030","article-title":"Evaluation of Ebola virus inhibitors for drug repurposing","volume":"1","author":"Madrid","year":"2015","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.jgar.2026.04.012_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174191","article-title":"Azithromycin: immunomodulatory and antiviral properties for SARS-CoV-2 infection","volume":"905","author":"Khezri","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jgar.2026.04.012_bib0033","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12941-021-00444-9","article-title":"Repurposing of antibiotics for clinical management of COVID-19: a narrative review","volume":"20","author":"Yacouba","year":"2021","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jgar.2026.04.012_bib0034","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(21)00149-5","article-title":"Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2026.04.012_bib0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jac\/dkab404","article-title":"Azithromycin in patients with COVID-19: a systematic review and meta-analysis","volume":"77","author":"Ayerbe","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.04.012_bib0036","series-title":"Ministerio de Salud: Actualmente no existe un tratamiento espec\u00edfico para la COVID-19","year":"2020"},{"key":"10.1016\/j.jgar.2026.04.012_bib0037","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis","volume":"27","author":"Langford","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2026.04.012_bib0038","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study","volume":"27","author":"Garcia-Vidal","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2026.04.012_bib0039","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/jac\/dkaa194","article-title":"COVID-19 and the potential long-term impact on antimicrobial resistance","volume":"75","author":"Rawson","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.04.012_bib0040","series-title":"Sistema de Salud en el Per\u00fa y el COVID-19","author":"Ponce de Le\u00f3n","year":"2021"},{"key":"10.1016\/j.jgar.2026.04.012_bib0041","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13054-021-03460-5","article-title":"Ventilator-associated pneumonia in critically ill patients with COVID-19","volume":"25","author":"Maes","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.jgar.2026.04.012_bib0042","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00134-020-06323-9","article-title":"Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study","volume":"47","author":"Rouz\u00e9","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jgar.2026.04.012_bib0043","first-page":"466","article-title":"Antimicrobial consumption from 2017 to 2021 in East Trinidad and Tobago: a study in the English-speaking Caribbean","volume":"12","author":"Nagassar","year":"2023","journal-title":"Antibiot 2023 Vol 12 Page 466"},{"key":"10.1016\/j.jgar.2026.04.012_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1642830","article-title":"Comparative assessment of antibacterial drugs used at the hospital level before and during COVID-19, according to the WHO AWaRe classification","volume":"16","author":"Balapasheva","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jgar.2026.04.012_bib0045","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.cmi.2025.06.009","volume":"31","author":"Meschiari","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2026.04.012_bib0046","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.ajic.2022.07.010","article-title":"Impact of an antimicrobial stewardship program in a COVID-19 reference hospital according to the AWaRe classification","volume":"50","author":"Telles","year":"2022","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jgar.2026.04.012_bib0047","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7326\/ANNALS-24-03078","article-title":"Impact of the COVID-19 Pandemic on antibiotic resistant infection burden in U.S. Hospitals","volume":"178","author":"Yek","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jgar.2026.04.012_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102257","article-title":"Antibiotic prescribing guideline recommendations in COVID-19: a systematic survey","volume":"65","author":"Langford","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jgar.2026.04.012_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261368","article-title":"Understanding the social drivers of antibiotic use during COVID-19 in Bangladesh: implications for reduction of antimicrobial resistance","volume":"16","author":"Kalam","year":"2021","journal-title":"PLoS One"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:29:43Z","timestamp":1781767783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716526000627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"alternative-id":["S2213716526000627"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2026.04.012","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of antimicrobial consumption in Peruvian public health services during the COVID-19 pandemic: A GLASS-AMU-based study","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2026.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}